GWM
AFMD

Geneos Wealth Management’s Affimed AFMD Stock Holding History

Geneos Wealth Management’s Portfolio AFMD Stock Details AFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,407
Closed -$79K – 2057
2016
Q4 		$79K Buy
+4,407
New +$95.1K 0.01% 678

Other funds holding AFMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NFA
Nationwide Fund Advisors Columbus, Ohio $2.28B AUM 12.16% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geneos Wealth Management's AFMD Position: Q1 2017 in Review

Geneos Wealth Management sold out of Affimed (AFMD) in Q1 2017, closing a stake of 4,407 shares — an estimated $79K sold.

Geneos Wealth Management first reported a position in AFMD in Q4 2016 and held it in 1 quarter. The position peaked at $79K in Q4 2016. 34 funds tracked by Wall St. Rank hold AFMD as of Q1 2017.

  • Geneos Wealth Management reported no remaining Affimed position as of Q1 2017 after selling out during the quarter.
  • Geneos Wealth Management sold 4,407 Affimed shares in Q1 2017, an estimated $79K.
  • Geneos Wealth Management first reported a position in Affimed in Q4 2016 and held it in 1 quarter.
  • Geneos Wealth Management's Affimed position peaked at $79K in Q4 2016.
  • 34 funds tracked by Wall St. Rank held Affimed as of Q1 2017.

Based on Geneos Wealth Management's 13F filing for Q1 2017, filed 7 Sep 2021.